BioMarin to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced participation in two virtual conferences, with live audio webcasts available for investors. The webcasts can be accessed at biomarin.com. An archived version will also be accessible post-conference. BioMarin focuses on developing therapies for rare disorders, boasting a portfolio of six commercial products and various clinical candidates. For more details, visit their website.

News Market Reaction – BMRN

+0.43%

+0.43% Session move

In the trading session that priced this news, BMRN gained 0.43%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., May 18, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301293332.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What conferences will BioMarin participate in May 2021?

BioMarin will participate in two upcoming virtual investor conferences.

Where can I watch BioMarin's conference webcasts?

The webcasts can be accessed live at BioMarin's investor relations website.

What is the focus of BioMarin Pharmaceutical?

BioMarin develops therapies for serious and life-threatening rare disorders.

How many products does BioMarin offer?

BioMarin has a portfolio that includes six commercialized products.

Is an archived version of the conference available?

Yes, an archived version will be available on BioMarin's website after the conference.